封面
市場調查報告書
商品編碼
2075480

醫用工程材料市場:按產品類型、應用、最終用戶和地區分類

Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,醫療工程材料市場規模將達到358.4億美元,2033年將達到869.7億美元。預計從2026年到2033年,該市場將以13.5%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 358.4億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 13.50% 預計金額(2033 年) 869.7億美元

醫用工程材料在醫療產業中扮演著至關重要的角色,為各種應用提供創新解決方案。這些材料經過專門設計,旨在滿足醫療設備、植入和其他醫療設備的獨特需求。它們具有卓越的強度、耐久性和生物相容性,確保安全有效的醫療解決方案。材料科學與工程的顯著進步正在拓展陶瓷、金屬、聚合物和複合材料在醫療領域的應用。此外,能夠忠實模擬人體組織並有助於組織再生的新型生物工程材料也正在研發中。隨著醫療程序和治療日益複雜,改善患者預後的需求推動了這些進步。總而言之,醫用工程材料產業在開發能夠推動醫學發展邁向新階段的創新材料解決方案方面發揮著至關重要的作用。

市場動態:

全球醫用工程材料市場的成長受到多種因素的驅動。心血管疾病、糖尿病和癌症等慢性疾病的日益普遍預計將推動對醫療設備和植入的需求成長。這些材料具有優異的性能,例如生物相容性、耐久性和柔軟性,這些性能對於開發先進的醫療設備至關重要。全球人口老化也是市場成長的推動因素之一。由於老年人更容易患慢性疾病,需要專業的醫療護理,因此醫用工程材料的應用變得至關重要。此外,材料科學領域的技術進步,例如利用奈米技術開發生物基材料和塗層,也進一步促進了市場成長。

然而,該市場也面臨許多挑戰。美國食品藥物管理局(FDA)等監管機構制定的嚴格法規和品質標準可能成為市場參與者的障礙。遵守這些法規並獲得新材料的監管批准可能耗時耗力。此外,醫療工程材料的研發和生產高成本,也可能阻礙市場成長。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數,對全球醫療工程材料市場的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球醫療工程材料市場》報告面向該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球醫療工程材料市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 慢性病盛行率增加
    • 嚴格的臨床和監管要求
    • 應用於個人化醫療
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 企業合併情景

第4章:全球醫療工程材料市場:依產品類型分類(2021-2033 年)

  • 金屬生物材料
  • 陶瓷和生物材料
  • 聚合物生物材料
  • 天然生物材料
  • 複合材料和生物材料
  • 其他

第5章:全球醫用工程材料市場:依應用領域分類(2021-2033年)

  • 心血管系統
  • 整形外科
  • 牙科
  • 整形外科
  • 創傷治療
  • 神經系統
  • 其他

第6章:全球醫療工程材料市場:依最終使用者分類(2021-2033 年)

  • 醫院
  • 診所
  • 研究機構
  • 其他

第7章 全球醫療工程材料市場:按地區分類(2021-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第8章:中東和非洲

  • 波灣合作理事會(GCC)國家
  • 以色列
  • 南非
  • 中非
  • 北非
  • 其他中東和非洲地區

第9章 競爭情勢

  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.
  • Others

第10章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI6308

Medical Engineered Materials Market is estimated to be valued at USD 35.84 Bn in 2026 and is expected to reach USD 86.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 35.84 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 13.50% 2033 Value Projection: USD 86.97 Bn

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.

Market Dynamics:

Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.

However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market

Medical Engineered Materials Market Detailed Segmentation:

  • By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Metallic Biomaterials
  • Ceramics Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials
  • Composites Biomaterials
  • Others
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Cardiovascular
  • Orthopedic
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Neuro-logical
  • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Research Institutions
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top companies in Global Medical Engineered Materials Market:
  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Medical Engineered Materials Market, By Product Type
    • Medical Engineered Materials Market, By Application
    • Medical Engineered Materials Market, By End User
    • Medical Engineered Materials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases
    • Stringent clinical & regulatory requirements
    • Applications in personalized medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Engineered Materials Market, By Product Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Ceramics Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Composites Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Medical Engineered Materials Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Neuro-logical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Medical Engineered Materials Market , By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Medical Engineered Materials Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022 -2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Argentina
      • Brazil
      • Mexico
      • Rest of Latin America

8. Middle East & Africa

  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • Central Africa
      • North Africa
      • Rest of Middle East

9. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Solvay
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SABIC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trelleborg AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DuPont de Nemours Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us